These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1810426

  • 1. Prophylactic anti-tumor effect of Hochu-ekki-to (TJ41) by enhancing natural killer cell activity.
    Cho JM, Sato N, Kikuchi K.
    In Vivo; 1991; 5(4):389-91. PubMed ID: 1810426
    [Abstract] [Full Text] [Related]

  • 2. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang).
    Harada M, Seta K, Ito O, Tamada K, Li T, Terao H, Takenoyama M, Kimura G, Nomoto K.
    Immunopharmacol Immunotoxicol; 1995 Nov; 17(4):687-703. PubMed ID: 8537606
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of immunological effects of hochu-ekki-to (TJ-41) prophylactic administration in mice.
    Cho S, Hong T, Kaneko A, Yoshino G, Sato N, Kikuchi K, Aikawa Y, Yasuno F, Inoue K, Cyong JC.
    Am J Chin Med; 2004 Nov; 32(2):235-43. PubMed ID: 15315261
    [Abstract] [Full Text] [Related]

  • 4. The protective effect of hochu-ekki-to (TJ-41), a Japanese herbal medicine, against HSV-1 infection in mitomycin C-treated mice.
    Kido T, Mori K, Daikuhara H, Tsuchiya H, Ishige A, Sasaki H.
    Anticancer Res; 2000 Nov; 20(6A):4109-13. PubMed ID: 11131680
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of natural killer cell activity and tumor immunity by diacetylputrescine.
    Bowlin TL, Rosenberger A, Stemerick D, Edwards ML.
    Cancer Res; 1990 Sep 01; 50(17):5460-3. PubMed ID: 2386950
    [Abstract] [Full Text] [Related]

  • 6. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
    Yagihashi A, Sato N, Torigoe T, Okubo M, Konno A, Takahashi N, Yamashita T, Fujinaga K, Kuzumaki N, Kikuchi K.
    Cancer Res; 1988 May 15; 48(10):2798-804. PubMed ID: 3162824
    [Abstract] [Full Text] [Related]

  • 7. Hochu-ekki-to combined with interferon-gamma moderately enhances daily activity of chronic fatigue syndrome mice by increasing NK cell activity, but not neuroprotection.
    Chen R, Moriya J, Luo X, Yamakawa J, Takahashi T, Sasaki K, Yoshizaki F.
    Immunopharmacol Immunotoxicol; 2009 Jun 15; 31(2):238-45. PubMed ID: 18791913
    [Abstract] [Full Text] [Related]

  • 8. Induction of tumor immunity and natural killer cell cytotoxicity in mice by 5-halo-6-phenyl pyrimidinone.
    Lotzová E, Savary CA, Pollack S, Hanna N.
    Cancer Res; 1986 Oct 15; 46(10):5004-8. PubMed ID: 3756861
    [Abstract] [Full Text] [Related]

  • 9. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
    Butler LD, Browne CP, Layman NK, Riedl P, Tang J, Marder P, DeLong D, Manetta J, Bobbitt L, Strnad J.
    Cancer Res; 1988 Nov 01; 48(21):6081-9. PubMed ID: 3048654
    [Abstract] [Full Text] [Related]

  • 10. Antimetastatic effect of CpG DNA mediated by type I IFN.
    Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, Männel DN.
    Cancer Res; 2001 Jul 15; 61(14):5523-8. PubMed ID: 11454702
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of glucocorticoid action on murine natural killer cell activity.
    Cox WI, Holbrook NJ, Friedman H.
    J Natl Cancer Inst; 1983 Nov 15; 71(5):973-81. PubMed ID: 6580499
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the activity of mouse natural killer cells by urethan.
    Gorelik E, Herberman RB.
    J Natl Cancer Inst; 1981 Mar 15; 66(3):543-8. PubMed ID: 6937709
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N, Schneider M.
    J Immunol; 1983 Feb 15; 130(2):974-80. PubMed ID: 6848604
    [Abstract] [Full Text] [Related]

  • 14. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A, Hansson M, Kiessling R, Andersson B, Kärre K, Roder J.
    J Natl Cancer Inst; 1980 May 15; 64(5):1113-9. PubMed ID: 6966004
    [Abstract] [Full Text] [Related]

  • 15. Natural killer target molecules associated with the transformation of the oncogene-transfected fibroblast.
    Cho JM, Sato N, Yagihashi A, Konno A, Hara I, Konn S, Torigoe T, Qi W, Takashima T, Takahashi N.
    Cancer Res; 1991 Aug 15; 51(16):4250-6. PubMed ID: 1868445
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J, Bennett M, Mann D, Kumar V.
    J Immunol; 1983 Dec 15; 131(6):2699-704. PubMed ID: 6644021
    [Abstract] [Full Text] [Related]

  • 17. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar 15; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

  • 18. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT.
    J Clin Invest; 1993 Dec 15; 92(6):2569-76. PubMed ID: 7504687
    [Abstract] [Full Text] [Related]

  • 19. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
    Rees RC, Reynolds CW, Herberman RB.
    Cancer Res; 1983 Sep 15; 43(9):4248-52. PubMed ID: 6871862
    [Abstract] [Full Text] [Related]

  • 20. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M, Herberman R, Gorelik E.
    Cancer Res; 1991 Oct 01; 51(19):5153-9. PubMed ID: 1913641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.